Status:
COMPLETED
Severe Fatigue in Stem Cell Transplantation
Lead Sponsor:
Gazi University
Conditions:
Stem Cell Transplantation
Fatigue
Eligibility:
All Genders
18-65 years
Brief Summary
Fatigue is a common symptom during allogeneic-hematopoietic stem cell transplantation (allo-HSCT). However, effects of severe fatigue on pulmonary functions, blood cells, dyspnea, muscle strength, exe...
Detailed Description
Fatigue is the most complained side effect that may last for months or even years after treatment ends in patients with cancer. Cancer-related fatigue is described as 'a distressing, persistent, subje...
Eligibility Criteria
Inclusion
- being an hematopoietic stem cell transplantation recipient during the intermediate/late post-transplant phase (\>100 days),
- 18-65 years of age
- under standard medications.
Exclusion
- having a cognitive disorder,
- orthopedic or neurological disease with a potential to affect functional capacity,
- comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute infections or pneumonia,
- problems which may prevent training such as visual problems and mucositis
- having metastasis to any region (bone etc.)
- having acute hemorrhage in the intracranial and / or lung and other areas
- having any contraindication to exercise training
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03448471
Start Date
March 1 2012
End Date
December 1 2017
Last Update
March 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University Faculty of Health Science Department of PhysioTherapy
Ankara, Turkey (Türkiye), 06010